Pcva Diabetes & Endo Midlothian, VA - 23114

Pcva Diabetes & Endo is categorized under Family Practice Doctors in Midlothian, VA and active since 2011.

Pcva Diabetes & Endo was established in 2011, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Kay Powers, Administrator at the company’s single location by writing to 348 Browns Hill Court, Midlothian, Virginia VA 23114 or by phoning (804) 212-2400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pcva Diabetes & Endo
Contact Person: Kay Powers, Administrator
Address: 348 Browns Hill Court, Midlothian, Virginia 23114
Phone Number: (804) 212-2400
Website Address: vadiabetes.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Family Practice Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Pcva Diabetes & Endo was started in 2011 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Kay Powers, Administrator for inquiries that concern Pcva Diabetes & Endo by calling the company number (804) 212-2400, as your correspondence is most welcome. Additionally, the physical location of the single location of Pcva Diabetes & Endo can be found at the coordinates 37.50056,-77.63956 as well as the street address 348 Browns Hill Court in Midlothian, Virginia 23114.

For its online presence, you may visit Pcva Diabetes & Endo’s website at vadiabetes.com and engage with its social media outlets through on Twitter and on Facebook.